Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR142 | Q7Z601 | 18/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | UBE2M | P61081 | 2/20 | 0.47 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2394766 | 0.87 | GPR142 (1.00) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2397268 | 0.86 | GPR142 (0.84) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL15259781 | 0.85 | GPR142 (0.87) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2395081 | 0.85 | GPR142 (0.81) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2395039 | 0.84 | GPR142 (0.91) | GPR142CYP3A4 | |
| SCHEMBL2391336 | 0.84 | GPR142 (1.00) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2392838 | 0.83 | GPR142 (1.00) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2389200 | 0.83 | GPR142 (0.78) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2393620 | 0.82 | GPR142 (0.81) | GPR142CYP3A4UBE2MDCUN1D1 | |
| SCHEMBL2393262 | 0.82 | GPR142 (0.78) | GPR142CYP3A4UBE2MDCUN1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8022061-B2 | 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions | AMGEN INC. (US) | 2011-09-20 | — | — | US | disclosed |